UnknownNCT05919277

A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires

Studying Dengue fever

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundacion GESICA
Principal Investigator
Alejandro Macchia, MD, MD
Fundacion GESICA
Intervention
Dengue Immunoglobulin G antibodies performed with ELISA(diagnostic_test)
Enrollment
1487 enrolled
Eligibility
18 years · All sexes
Timeline
2023 – 2024

Study locations (1)

Collaborators

Merck Sharp & Dohme LLC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05919277 on ClinicalTrials.gov

Other trials for Dengue fever

Additional recruiting or active studies for the same condition.

See all trials for Dengue fever →

← Back to all trials